Cellular sterol trafficking and metabolism: spotlight on structure

Current Opinion in Cell Biology

Volumn 20, Issue 4, 2008, Pages 371-377

  Ikonen, Elina ^a   Jansen, Maurice ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL; HUNTINGTIN; OXIDOREDUCTASE; PROTEIN DHCR 24; STEROL;

CATALYSIS; CELL MEMBRANE; CELL METABOLISM; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; YEAST;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; METABOLIC NETWORKS AND PATHWAYS; STEROLS;

EUKARYOTA;

EID: 47149103256     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2008.03.017     Document Type: Review

References (55)

1. Ikonen E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev 86 (2006) 1237-1261
2. •] summarizes our current knowledge on how proteins can contribute to intracellular sterol trafficking and distribution. Additionally, the effect of the lipid environment on the chemical potential of sterols is discussed.
3. •].
4. Wustner D. Fluorescent sterols as tools in membrane biophysics and cell biology. Chem Phys Lipids 146 (2007) 1-25. This review gives an overview of a variety of fluorescent sterols used in cell biology and biophysics.
5. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 9 (2008) 125-138. This review provides a general discussion of the physiology of cholesterol trafficking in mammalian cells.
6. Reiner S., Micolod D., Zellnig G., and Schneiter R. A genomewide screen reveals a role of mitochondria in anaerobic uptake of sterols in yeast. Mol Biol Cell 17 (2006) 90-103. This paper reports on a S. cerevisiae screen for sterol uptake in anaerobic conditions and identifies mitochondrial functions as required for sterol uptake and/or transport.
7. Fei W., Alfaro G., Muthusamy B.P., Klaassen Z., Graham T.R., Yang H., and Beh C.T. Genome-wide analysis of sterol-lipid storage and trafficking in Saccharomyces cerevisiae. Eukaryot Cell 7 (2008) 401-414. This study characterizes new mutants that alter the localization and/or amounts of unesterified sterols and steryl esters in yeast.
8. Wilcox L.J., Balderes D.A., Wharton B., Tinkelenberg A.H., Rao G., and Sturley S.L. Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 277 (2002) 32466-32472
9. Li Y., and Prinz W.A. ATP-binding cassette (ABC) transporters mediate nonvesicular, raft-modulated sterol movement from the plasma membrane to the endoplasmic reticulum. J Biol Chem 279 (2004) 45226-45234
10. Tinkelenberg A.H., Liu Y., Alcantara F., Khan S., Guo Z., Bard M., and Sturley S.L. Mutations in yeast ARV1 alter intracellular sterol distribution and are complemented by human ARV1. J Biol Chem 275 (2000) 40667-40670
11. Beh C.T., and Rine J. A role for yeast oxysterol-binding protein homologs in endocytosis and in the maintenance of intracellular sterol-lipid distribution. J Cell Sci 117 (2004) 2983-2996
12. Kajiwara K., Watanabe R., Pichler H., Ihara K., Murakami S., Riezman H., and Funato K. Yeast ARV1 IS required for efficient delivery of an early GPI intermediate to the first mannosyltransferase during GPI assembly and controls lipid flow from the ER. Mol Biol Cell (2008). This study provides evidence that in yeast GPI-anchor synthesis and attachment to proteins regulate ceramide transport from the ER and intracellular sterol distribution.
13. Funato K., and Riezman H. Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast. J Cell Biol 155 (2001) 949-959
14. Bloch K. The biological synthesis of cholesterol. Science 150 (1965) 19-28
15. Gaylor J.L. Membrane-bound enzymes of cholesterol synthesis from lanosterol. Biochem Biophys Res Commun 292 (2002) 1139-1146
16. Lusa S., Heino S., and Ikonen E. Differential mobilization of newly synthesized cholesterol and biosynthetic sterol precursors from cells. J Biol Chem 278 (2003) 19844-19851
17. Byskov A.G., Andersen C.Y., Nordholm L., Thogersen H., Xia G., Wassmann O., Andersen J.V., Guddal E., and Roed T. Chemical structure of sterols that activate oocyte meiosis. Nature 374 (1995) 559-562
18. Johnson W.J., Fischer R.T., Phillips M.C., and Rothblat G.H. Efflux of newly synthesized cholesterol and biosynthetic sterol intermediates from cells. Dependence on acceptor type and on enrichment of cells with cholesterol. J Biol Chem 270 (1995) 25037-25046
19. Mutka A.L., Lusa S., Linder M.D., Jokitalo E., Kopra O., Jauhiainen M., and Ikonen E. Secretion of sterols and the NPC2 protein from primary astrocytes. J Biol Chem 279 (2004) 48654-48662
20. Jansen M., Pietiainen V.M., Polonen H., Rasilainen L., Koivusalo M., Ruotsalainen U., Jokitalo E., and Ikonen E. Cholesterol substitution increases the structural heterogeneity of caveolae. J Biol Chem (2008). By substituting cellular cholesterol for desmosterol, this paper shows that a small change in sterol structure interferes with the specific sterol-caveolin interaction and perturbs the structure of caveolae.
21. Vainio S., Jansen M., Koivusalo M., Rog T., Karttunen M., Vattulainen I., and Ikonen E. Significance of sterol structural specificity. Desmosterol cannot replace cholesterol in lipid rafts. J Biol Chem 281 (2006) 348-355
22. Cao J., Wang J., Qi W., Miao H.H., Wang J., Ge L., DeBose-Boyd R.A., Tang J.J., Li B.L., and Song B.L. Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. Cell Metab 6 (2007) 115-128
23. Lange Y., Ory D.S., Ye J., Lanier M.H., Hsu F.F., and Steck T.L. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 283 (2008) 1445-1455. Changes in cellular cholesterol result in acute responses in the pool of ER cholesterol and the rate of cholesterol esterification. This paper shows that SREBP-dependent gene expression is not required for these responses. It was also found that the conversion of cholesterol to 27-hydroxycholesterol is required for the acute proteolytic inactivation of HMG-CoA reductase triggered by cholesterol.
24. Hughes A.L., Powell D.W., Bard M., Eckstein J., Barbuch R., Link A.J., and Espenshade P.J. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5 (2007) 143-149
25. Raychaudhuri S., Im Y.J., Hurley J.H., and Prinz W.A. Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein-related proteins and phosphoinositides. J Cell Biol 173 (2006) 107-119
26. Yan D., and Olkkonen V.M. Characteristics of oxysterol binding proteins. Int Rev Cytol 265 (2008) 253-285
27. Yamauchi Y., Reid P.C., Sperry J.B., Furukawa K., Takeya M., Chang C.C., and Chang T.Y. Plasma membrane rafts complete cholesterol synthesis by participating in retrograde movement of precursor sterols. J Biol Chem 282 (2007) 34994-35004. This paper shows that upon arrival at the PM, the conversion of precursor sterols to cholesterol is slowed down when the PM sterol content is decreased but that the conversion is largely independent of the NPC proteins.
28. Tiwari R., Koffel R., and Schneiter R. An acetylation/deacetylation cycle controls the export of sterols and steroids from S. cerevisiae. EMBO J 26 (2007) 5109-5119. This paper reports the identification of sterol acetylation in yeast. The cycle of acetylation/deacetylation is linked to sterol secretion and appears at least partly conserved in humans.
29. Strott C.A. Sulfonation and molecular action. Endocr Rev 23 (2002) 703-732
30. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40 (2000) 581-616
31. ••] determined the crystal structure of a membrane attack complex/perforin domain and proposes that lytic MACPF proteins use a cholesterol-dependent cytolysin-like mechanism of membrane insertion.
32. ••].
33. Martin J.R., Raibaud A., and Ollo R. Terminal pattern elements in Drosophila embryo induced by the torso-like protein. Nature 367 (1994) 741-745
34. Zheng C., Heintz N., and Hatten M.E. CNS gene encoding astrotactin, which supports neuronal migration along glial fibers. Science 272 (1996) 417-419
35. Adams C.M., Reitz J., De Brabander J.K., Feramisco J.D., Li L., Brown M.S., and Goldstein J.L. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem 279 (2004) 52772-52780
36. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., and Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A 104 (2007) 6511-6518. This study defines Insig as a membrane bound oxysterol-binding protein with specificity for cholesterol derivatives that possess hydroxyl groups on the side chain.
37. Sun L.P., Seemann J., Goldstein J.L., and Brown M.S. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc Natl Acad Sci U S A 104 (2007) 6519-6526. This article shows that both cholesterol binding to Scap and oxysterol binding to Insig independently induce a similar conformational change in the cytoplasmic loop 6 of Scap that prevents the COPII proteins from gaining access to the MELADL sorting sequence. The authors hypothesize that the distance of the MELADL sequence from the membrane is crucial for sterol-mediated regulation of COPII accessibility of Scap.
38. Infante R.E., Abi-Mosleh L., Radhakrishnan A., Dale J.D., Brown M.S., and Goldstein J.L. Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein. J Biol Chem 283 (2008) 1052-1063. This study identified NPC1 as an oxysterol-binding protein but showed that NPC1 is not required for the known regulatory actions of oxysterols.
39. Infante R.E., Radhakrishnan A., Abi-Mosleh L., Kinch L.N., Wang M.L., Grishin N.V., Goldstein J.L., and Brown M.S. Purified NPC1 protein. II. Localization of sterol binding to a 240-amino acid soluble luminal loop. J Biol Chem 283 (2008) 1064-1075. In this article NPC1 was shown to contain a sterol-binding site in a soluble luminal loop. The authors propose that this binding site is not essential for NPC1 function in fibroblasts, but it may function in other cells where NPC1 deficiency produces more complicated lipid abnormalities.
40. Liou H.L., Dixit S.S., Xu S., Tint G.S., Stock A.M., and Lobel P. NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols. J Biol Chem 281 (2006) 36710-36723
41. Xu S., Benoff B., Liou H.L., Lobel P., and Stock A.M. Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease. J Biol Chem 282 (2007) 23525-23531. By analyzing the structure of both apo-bound and sterol-bound NPC2, this study provides evidence for a malleable-binding site which is consistent with the previously documented broad range of sterol ligand specificity.
42. Gondre-Lewis M.C., Petrache H.I., Wassif C.A., Harries D., Parsegian A., Porter F.D., and Loh Y.P. Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature. J Cell Sci 119 (2006) 1876-1885. By using cells with a defect in cholesterol biosynthesis this study shows that sterol structure is important for granule formation and correlates granule size and bending rigidity to sterol structure.
43. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., and Nitsch R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20 (2000) 7345-7352
44. Luciani P., Gelmini S., Ferrante E., Lania A., Benvenuti S., Baglioni S., Mantovani G., Cellai I., Ammannati F., Spada A., et al. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 90 (2005) 6156-6161
45. Di Stasi D., Vallacchi V., Campi V., Ranzani T., Daniotti M., Chiodini E., Fiorentini S., Greeve I., Prinetti A., Rivoltini L., et al. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis. Int J Cancer 115 (2005) 224-230
46. Kuehnle K., Crameri A., Kalin R.E., Luciani P., Benvenuti S., Peri A., Ratti F., Rodolfo M., Kulic L., Heppner F.L., et al. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 28 (2008) 539-550. This study solved the paradox that DHCR24 can both confer senescence and protection against oxidative stress by showing that that it functions by two mechanistically independent pathways; one involves cholesterol and the other p53.
47. Wu C., Miloslavskaya I., Demontis S., Maestro R., and Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432 (2004) 640-645
48. Crameri A., Biondi E., Kuehnle K., Lutjohann D., Thelen K.M., Perga S., Dotti C.G., Nitsch R.M., Ledesma M.D., and Mohajeri M.H. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25 (2006) 432-443. This paper links the protective effect of DHCR24/Seladin-1 against Aβ-mediated toxicity with its sterol reductase activity by showing that lack of DHCR24 reduces γ-secretase DRM localization.
49. Brewer Jr. H.B. HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease. Curr Cardiol Rep 9 (2007) 486-492
50. Terasaka N., Wang N., Yvan-Charvet L., and Tall A.R. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci U S A 104 (2007) 15093-15098. This study indicates a specific role for ABCG1 in promoting efflux of 7-ketocholesterol and related oxysterols from macrophages onto HDL and in protecting these cells from oxysterol-induced cytotoxicity.
51. Wang N., Yvan-Charvet L., Lutjohann D., Mulder M., Vanmierlo T., Kim T.W., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J 22 (2008) 1073-1082. This article provides the first direct evidence for a role of Abcg4 in efflux of sterol from astrocytes to HDL in the brain. The active efflux of desmosterol was shown to involve Abcg1, Abcg4, and Abca1, suggesting that this sterol has an important role in brain sterol homeostasis.
52. Dietschy J.M., and Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45 (2004) 1375-1397
53. Valenza M., Rigamonti D., Goffredo D., Zuccato C., Fenu S., Jamot L., Strand A., Tarditi A., Woodman B., Racchi M., et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 25 (2005) 9932-9939
54. Valenza M., Carroll J.B., Leoni V., Bertram L.N., Bjorkhem I., Singaraja R.R., Di Donato S., Lutjohann D., Hayden M.R., and Cattaneo E. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet 16 (2007) 2187-2198. This study suggests that huntingtin influences cholesterol biosynthesis by showing that overexpression of mutant or wild-type huntingtin in mice results in the upregulation or downregulation of cholesterol biosynthesis, respectively.
55. Trushina E., Singh R.D., Dyer R.B., Cao S., Shah V.H., Parton R.G., Pagano R.E., and McMurray C.T. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet 15 (2006) 3578-3591